WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, , and C03.


C05 VASOPROTECTIVES

No DDDs are established in this group, since most of the drugs in this group are for topical use.


C05B ANTIVARICOSE THERAPY

This group comprises all products for treatment of varices, i.v. infusion induced thrombophlebitis etc.
Zinc bandages, see D09A - Medicated dressings.


C05BA Heparins or heparinoids for topical use

Heparin in combination with e.g. dexpanthenol and allantoin is classified in C05BA53.
Heparin in combination with diclofenac for topical use is classified in M02AA15.
Heparinoids in combination with calcium dobesilate are classified in C05BX - Other sclerosing agents.


List of abbreviations

Last updated: 2023-01-23